Aquaculture biotechnology group Benchmark moved a step closer to reaching the necessary approvals required to launch its new medicinal sea lice treatment, BMK08, after receiving a “positive opinion”
The next milestone is getting approval and ratification from the European Commission.
Aquaculture biotechnology group Benchmark moved a step closer to reaching the necessary approvals required to launch its new medicinal sea lice treatment, BMK08, after receiving a “positive opinion”